John Rozel, MD, MSL
Associate Professor of Psychiatry & Adjunct Professor of Law University of Pittsburgh
Medical Director, resolve Crisis Services Western Psychiatric Institute and Clinic of UPMC
Dr. Rozel has been working in emergency mental health for over 25 years and has been the medical director of resolve Crisis Services since 2010. He is the President of the American Association for Emergency Psychiatry, the leading national organization dedicated to the improvement of compassionate, evidence based care for people with psychiatric emergencies. He is board certified in general, child and forensic psychiatry. Dr. Rozel is a Fellow of the American Psychiatric Association and a 2018 recipient of the Exemplary Psychiatrist award from the National Alliance on Mental Illness.
Dr. Rozel regularly provides clinical and didactic training to medical students, residents and fellows at the University of Pittsburgh School of Medicine; mentors graduate students through the Center for Bioethics and Health Law; co-teaches the Mental Health Law course at the School of Law; and teaches regional law enforcement professionals through the Crisis Intervention Team training program. He is the creator of the Clinical Homicide and Aggression Management Practices for Inpatient, Outpatient and Nontraditional Settings (CHAMPIONS) training.
Dr. Rozel earned a Bachelor’s degree in Biomedical Ethics and his MD at Brown University. He received a Master of Studies in Law from the University of Pittsburgh. He completed his general psychiatry residency and child and forensic psychiatry fellowships at Western Psychiatric Institute and Clinic of UPMC.
Jessica S. Merlin MD, PhD, MBA
Associate Professor of Medicine, Tenure Stream
Dr. Merlin is a physician and is board certified in internal medicine, infectious disease, palliative care, and addiction medicine, and runs a pain and palliative care clinic embedded in an HIV patient-centered medical home. She is also a PhD-trained behavioral scientist and NIH-funded clinician-investigator. Her research includes foundational work on the pathophysiology, clinical epidemiology, and behavioral management of chronic pain in people with HIV. This work has extended to management approaches to pain and opioid misuse/use disorder in individuals with serious illness in palliative care settings. She has been recognized nationally for her work with three Young Investigator awards from relevant societies, an Inspirational Leader Under 40 Award from the American Academy of Hospice and Palliative Medicine, and a Cambia Foundation Sojourns Scholar Leadership Award. She is an active scientific mentor to trainees at the doctoral, post-doctoral, and junior faculty level, as is the Director of Mentoring for Pitt's Institute for Clinical Research Education as well as the Associate Program Director for Research for Pitt's Internal Medicine residency and Director of the General Internal Medicine research fellowship.
Michelle Schreiber, MSN, RN, CCM
Clinical Education Coordinator, Clinical Training & Education, UPMC Health Plan
Michele Gordon, PhD, LSW
Program Manager, Clinical Training & Education, UPMC Health Plan
Conflict of Interest Disclosure
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.